Ovarian Cancer Clinical Trial 20203530

[LCID Study Number: 20203530]

Label-free Hyperspectral Imaging for Intra-operative Classification of Platinum-resistant Ovarian Cancer

The purpose of this study is to test the clinical feasibility to differentiate platinum-sensitive from platinum-resistant ovarian cancer metastases during operative debulking using a hyperspectral imaging laparoscopic prototype.

Disease/Condition: Ovarian Cancer

Department: Gynecology

Location(s): Lahey Hospital & Medical Center (Burlington); Lahey Medical Center, Peabody; Winchester Hospital

Protocol #: 20203530
Principal Investigator(s): Caroline Nitschmann
Trial Phase: Investigator Initiated Study Observational